Alternatives to Joint Replacement Surgery in Springfield, MO

What I’d check before adding non surgical alternatives to joint replacement here

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 11.1% of adults in Springfield have diagnosed diabetes — 0.9 points below the U.S. 12% figure. 10% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick non surgical alternatives to joint replacement against that mix.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 27% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 10% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Missouri.
• Population 169,176 (Census city proper) understates metro demand and overstates how many of those people will ever see a biologic. Use it as scale, then underwrite against clinic specialty mix.
• Joint-preservation biologics compete with cortisone and viscosupplementation pathways that already have familiar CPT habits. The operational gap in Missouri is staff training and consent language, not another brand name on a centrifuge.

Payer geography for Springfield, MO

J5 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Springfield is 11.1% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic